5-Iodo-7-(2-C-methyl-beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine structure
|
Common Name | 5-Iodo-7-(2-C-methyl-beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine | ||
|---|---|---|---|---|
| CAS Number | 847551-49-9 | Molecular Weight | 406.18 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C12H15IN4O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 5-Iodo-7-(2-C-methyl-beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine4-Amino-5-iodo-7-(2-β-C-methyl-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 5-iodo-7-(2-C-methyl-β-D-ribofuranosyl) |
|---|---|
| Synonym | More Synonyms |
| Description | 4-Amino-5-iodo-7-(2-β-C-methyl-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C12H15IN4O4 |
|---|---|
| Molecular Weight | 406.18 |
| Exact Mass | 406.01400 |
| PSA | 126.65000 |
| LogP | 0.20090 |
| InChIKey | VDPOJGOZLKLNFY-YUTYNTIBSA-N |
| SMILES | CC1(O)C(O)C(CO)OC1n1cc(I)c2c(N)ncnc21 |
| 5-iodo-7-(2-c-methyl-beta-d-ribofuranosyl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine |